Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer

Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer

Bibliographic Details
Main Authors: Lu, C-Y, Tsai, H-L, Uen, Y-H, Hu, H-M, Chen, C-W, Cheng, T-L, Lin, S-R, Wang, J-Y
Format: Online
Language:English
Published: Nature Publishing Group 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590657/
id pubmed-3590657
recordtype oai_dc
spelling pubmed-35906572014-03-05 Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer Lu, C-Y Tsai, H-L Uen, Y-H Hu, H-M Chen, C-W Cheng, T-L Lin, S-R Wang, J-Y Clinical Study Nature Publishing Group 2013-03-05 2013-02-19 /pmc/articles/PMC3590657/ /pubmed/23422758 http://dx.doi.org/10.1038/bjc.2012.595 Text en Copyright © 2013 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Lu, C-Y
Tsai, H-L
Uen, Y-H
Hu, H-M
Chen, C-W
Cheng, T-L
Lin, S-R
Wang, J-Y
spellingShingle Lu, C-Y
Tsai, H-L
Uen, Y-H
Hu, H-M
Chen, C-W
Cheng, T-L
Lin, S-R
Wang, J-Y
Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer
author_facet Lu, C-Y
Tsai, H-L
Uen, Y-H
Hu, H-M
Chen, C-W
Cheng, T-L
Lin, S-R
Wang, J-Y
author_sort Lu, C-Y
title Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer
title_short Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer
title_full Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer
title_fullStr Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer
title_full_unstemmed Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer
title_sort circulating tumor cells as a surrogate marker for determining clinical outcome to mfolfox chemotherapy in patients with stage iii colon cancer
description
publisher Nature Publishing Group
publishDate 2013
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590657/
_version_ 1611960337649631232

Similar Items